Stratos Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.9M | Buy |
33,919
+2,482
| +8% | +$885K | 0.14% | 157 |
|
|
2025
Q4 | $10.3M | Buy |
31,437
+147
| +0.5% | +$46.6K | 0.12% | 188 |
|
|
2025
Q3 | $8.83M | Buy |
31,290
+3,045
| +11% | +$883K | 0.1% | 198 |
|
|
2025
Q2 | $7.89M | Buy |
28,245
+2,899
| +11% | +$821K | 0.11% | 200 |
|
|
2025
Q1 | $7.9M | Sell |
25,346
-1,788
| -7% | -$528K | 0.12% | 178 |
|
|
2024
Q4 | $7.07M | Sell |
27,134
-1,895
| -7% | -$562K | 0.1% | 207 |
|
|
2024
Q3 | $9.35M | Buy |
29,029
+3,658
| +14% | +$1.2M | 0.14% | 158 |
|
|
2024
Q2 | $7.93M | Buy |
25,371
+133
| +0.5% | +$39.1K | 0.13% | 163 |
|
|
2024
Q1 | $7.18M | Buy |
25,238
+326
| +1% | +$95.4K | 0.12% | 180 |
|
|
2023
Q4 | $7.18M | Buy |
24,912
+946
| +4% | +$258K | 0.13% | 168 |
|
|
2023
Q3 | $6.44M | Buy |
23,966
+4,050
| +20% | +$1.01M | 0.14% | 165 |
|
|
2023
Q2 | $4.42M | Buy |
19,916
+1,864
| +10% | +$433K | 0.1% | 211 |
|
|
2023
Q1 | $4.36M | Sell |
18,052
-1,772
| -9% | -$435K | 0.12% | 180 |
|
|
2022
Q4 | $5.21M | Buy |
19,824
+919
| +5% | +$246K | 0.13% | 169 |
|
|
2022
Q3 | $4.26M | Sell |
18,905
-596
| -3% | -$144K | 0.12% | 174 |
|
|
2022
Q2 | $4.75M | Sell |
19,501
-438
| -2% | -$107K | 0.12% | 174 |
|
|
2022
Q1 | $4.82M | Sell |
19,939
-11,689
| -37% | -$2.69M | 0.11% | 196 |
|
|
2021
Q4 | $7.12M | Sell |
31,628
-256
| -0.8% | -$54K | 0.16% | 138 |
|
|
2021
Q3 | $6.78M | Sell |
31,884
-762
| -2% | -$175K | 0.17% | 124 |
|
|
2021
Q2 | $7.96M | Buy |
32,646
+556
| +2% | +$137K | 0.2% | 110 |
|
|
2021
Q1 | $7.98M | Buy |
32,090
+78
| +0.2% | +$18.6K | 0.22% | 98 |
|
|
2020
Q4 | $7.36M | Sell |
32,012
-626
| -2% | -$144K | 0.22% | 105 |
|
|
2020
Q3 | $8.29M | Sell |
32,638
-113
| -0.3% | -$28K | 0.27% | 86 |
|
|
2020
Q2 | $7.72M | Buy |
32,751
+1,557
| +5% | +$355K | 0.28% | 80 |
|
|
2020
Q1 | $6.32M | Buy |
31,194
+5,147
| +20% | +$1.12M | 0.29% | 77 |
|
|
2019
Q4 | $6.28M | Buy |
26,047
+274
| +1% | +$60.4K | 0.25% | 86 |
|
|
2019
Q3 | $4.99M | Buy |
25,773
+16
| +0.1% | +$3.07K | 0.22% | 101 |
|
|
2019
Q2 | $4.75M | Buy |
25,757
+522
| +2% | +$93.5K | 0.21% | 105 |
|
|
2019
Q1 | $4.79M | Buy |
25,235
+61
| +0.2% | +$11.6K | 0.22% | 97 |
|
|
2018
Q4 | $4.9M | Buy |
+25,174
| New | +$4.91M | 0.25% | 80 |
|
|
2018
Q3 | – | Sell |
-25,746
| Closed | -$4.75M | – | 2961 |
|
|
2018
Q2 | $4.75M | Sell |
25,746
-1,929
| -7% | -$341K | 0.21% | 99 |
|
|
2018
Q1 | $4.72M | Sell |
27,675
-23,049
| -45% | -$4.23M | 0.2% | 110 |
|
|
2017
Q4 | $8.82M | Sell |
50,724
-3,639
| -7% | -$644K | 0.4% | 46 |
|
|
2017
Q3 | $10.1M | Buy |
+54,363
| New | +$9.63M | 0.48% | 41 |
|
|
2017
Q1 | – | Sell |
-43,669
| Closed | -$6.38M | – | 801 |
|
|
2016
Q4 | $6.38M | Buy |
43,669
+4,412
| +11% | +$664K | 0.4% | 54 |
|
|
2016
Q3 | $6.55M | Buy |
39,257
+3,776
| +11% | +$639K | 0.44% | 50 |
|
|
2016
Q2 | $5.4M | Buy |
+35,481
| New | +$5.52M | 0.4% | 49 |
|
|
2016
Q1 | – | Sell |
-25,828
| Closed | -$4.19M | – | 590 |
|
|
2015
Q4 | $4.19M | Buy |
+25,828
| New | +$4.06M | 0.35% | 57 |
|
|
2014
Q3 | – | Sell |
-13,613
| Closed | -$1.61M | – | 326 |
|
|
2014
Q2 | $1.61M | Buy |
+13,613
| New | +$1.58M | 0.54% | 54 |
|
Other funds holding AMGN
VCM
VPM
Stratos Wealth Partners's AMGN Position: Q1 2026 in Review
Stratos Wealth Partners increased its Amgen (AMGN) stake by 7.9% in Q1 2026, buying an estimated $885K and bringing the position to 33,919 shares worth $11.9M. The position accounts for 0.14% of the portfolio, ranked #157.
Stratos Wealth Partners first reported a position in AMGN in Q2 2014 and has held it in 39 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Stratos Wealth Partners held 33,919 shares of Amgen worth $11.9M as of Q1 2026.
- Stratos Wealth Partners bought 2,482 Amgen shares in Q1 2026, an estimated $885K.
- Amgen made up 0.14% of Stratos Wealth Partners's portfolio in Q1 2026, its #157 holding.
- Stratos Wealth Partners first reported a position in Amgen in Q2 2014 and has held it in 39 quarters since.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.